HomeAdvanced Structural Intervention Scores › TRILUMINATE TR Severity (5-Grade) Calculator

TRILUMINATE TR Severity (5-Grade) Calculator

  • Vena contracta width (VC) (mm)
  • Effective regurgitant orifice area (EROA) (mm2) (optional but recommended)
  • Regurgitant volume (RVol) (mL/beat) (optional)
  • Vena contracta area (VCA) (cm2) (optional; 3D/planimetry)
  • TRILUMINATE TR Severity (5-Grade) Calculator: Explanation and Clinical Context
    This calculator classifies tricuspid regurgitation (TR) severity according to the 5-grade scheme used in the TRILUMINATE program (trace/mild, moderate, severe, massive, torrential). It integrates quantitative echocardiographic parameters — vena contracta (VC), effective regurgitant orifice area (EROA), regurgitant volume (RVol), and 3D vena contracta area (VCA) — using evidence-based thresholds.

    Thresholds:
    VC (mm): <3 mild, 3–6 moderate, 7–13 severe, 14–20 massive, ≥21 torrential.
    EROA (mm²): <20 mild, 20–39 moderate, 40–59 severe, 60–79 massive, ≥80 torrential.
    RVol (mL/beat): <30 mild, 30–44 moderate, 45–59 severe, 60–74 massive, ≥75 torrential.
    VCA (cm²): <0.43 mild, 0.43–0.67 moderate, 0.68–0.88 severe, 0.89–1.26 massive, >1.26 torrential.

    Clinical Significance:
    The 5-grade TR classification enhances discrimination in advanced disease and post-TEER follow-up. It was used in TRILUMINATE to guide analysis of procedural success, prognosis, and health-status improvement. Patients achieving ≤ moderate TR after edge-to-edge repair show greater KCCQ and 6-minute walk improvement compared with those with persistent severe TR.

    References:
    Sorajja P, et al. N Engl J Med. 2023;388:1833–1844.
    ClinicalTrials.gov. NCT03904147 (TRILUMINATE Pivotal).
    Ambrosino M, et al. J Am Heart Assoc. 2024;13:e032999.
    Go YY, et al. Front Cardiovasc Med. 2018;5:164.
    Miura M, et al. JACC Cardiovasc Interv. 2020;13:2244–2255.
    Arnold SV, et al. J Am Coll Cardiol. 2024;83:105–117.
    Benzoni G, et al. 2025 (VCA thresholds for STR severity).
    Tang GHL, et al. TRILUMINATE Randomized Cohort, 2025.

Discussion


No discussions yet. Be the first to comment.

Create Note

Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.

My Notes

Report this Tool